SCHEMBL28056153

SCHEMBL28056153

CC(=O)Oc1nc2ccc(Oc3ccccc3)cc2s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
MAPT P10636 5/20 0.57
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
HTT P42858 3/20 0.57
TP53 P04637 1/20 0.57
CA2 P00918 3/20 0.50
LMNA P02545 3/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C19 P33261 2/20 0.50
KDM4E B2RXH2 2/20 0.50
CYP2D6 P10635 1/20 0.50
HPGD P15428 1/20 0.50
SCN4A P35499 1/20 0.47
SCN9A Q15858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4519276 0.81 SMN1; SMN2 (0.62) TDP1L3MBTL1MAPTNPC1RAB9A
SCHEMBL5131881 0.78 CYP1A2 (0.56) L3MBTL1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11278674 0.78 NPC1 (0.74) TDP1L3MBTL1MAPTNPC1RAB9A
SCHEMBL4514258 0.77 SMN1; SMN2 (0.49) TDP1L3MBTL1MAPTNPC1RAB9A
SCHEMBL28876415 0.77 CYP1A2 (0.55) L3MBTL1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL16398809 0.76 ALDH1A1 (0.63) TDP1L3MBTL1MAPTNPC1RAB9A
SCHEMBL202432 0.76 TDP1 (1.00) TDP1L3MBTL1MAPTNPC1RAB9A
SCHEMBL28056154 0.75 MAPT (0.58) TDP1L3MBTL1MAPTNPC1RAB9A
SCHEMBL10935498 0.74 NPC1 (0.75) TDP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL4518562 0.74 ACACB (0.58) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105408325-A Cyanotriazole compounds OTSUKA PHARMA CO LTD 2016-03-16 CN disclosed